Inventor
GILLIS ERIC P
US37 patents
⚠️ This page may combine multiple inventors who share the name “GILLIS ERIC P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
15 patentsUS9308236B2Apr 12, 2016
Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
BRISTOL MYERS SQUIBB CO51 citations96
US9879046B2Jan 30, 2018
Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
BRISTOL MYERS SQUIBB CO17 citations93
US10143746B2Dec 4, 2018
Immunomodulators
BRISTOL MYERS SQUIBB CO9 citations84
US9944678B2Apr 17, 2018
Immunomodulators
BRISTOL MYERS SQUIBB CO8 citations84
US9732119B2Aug 15, 2017
Immunomodulators
BRISTOL MYERS SQUIBB CO14 citations84
US10538555B2Jan 21, 2020
Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
BRISTOL MYERS SQUIBB CO8 citations83
US9850283B2Dec 26, 2017
Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
BRISTOL MYERS SQUIBB CO12 citations82
US10358463B2Jul 23, 2019
Immunomodulators
BRISTOL MYERS SQUIBB CO7 citations73
US10450347B2Oct 22, 2019
Immunomodulators
BRISTOL MYERS SQUIBB CO6 citations72
US9527885B2Dec 27, 2016
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO1 citations50
US9422311B2Aug 23, 2016
Compounds for the treatment of hepatitis C
BRISTOL MYERS SQUIBB CO0 citations42
US9598433B2Mar 21, 2017
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO0 citations41
US9334279B2May 10, 2016
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO0 citations41
US9643999B2May 9, 2017
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO0 citations40
US9499550B2Nov 22, 2016
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO0 citations39
UNIV ILLINOIS
10 patentsUS8013203B2Sep 6, 2011
System for controlling the reactivity of boronic acids
UNIV ILLINOIS13 citations92
US10239824B2Mar 26, 2019
Automated synthesis of small molecules using chiral, non-racemic boronates
UNIV ILLINOIS1 citations72
US9845317B2Dec 19, 2017
Slow release of organoboronic acids in cross-coupling reactions
UNIV ILLINOIS1 citations62
US9328102B2May 3, 2016
Slow release of organoboronic acids in cross-coupling reactions
UNIV ILLINOIS2 citations62
US9006463B2Apr 14, 2015
Slow release of organoboronic acids in cross-coupling reactions
UNIV ILLINOIS3 citations62
US9732102B2Aug 15, 2017
System for controlling the reactivity of boronic acids
UNIV ILLINOIS0 citations52
US9328127B2May 3, 2016
System for controlling the reactivity of boronic acids
UNIV ILLINOIS0 citations52
US10752577B2Aug 25, 2020
Automated synthesis of small molecules using chiral, non-racemic boronates
UNIV ILLINOIS0 citations51
US9388131B2Jul 12, 2016
Automated synthesis of small molecules using chiral, non-racemic boronates
UNIV ILLINOIS0 citations51
US9908900B2Mar 6, 2018
Methods for forming protected organoboronic acids
UNIV ILLINOIS0 citations48
BURKE MARTIN D
7 patentsUS8338601B2Dec 25, 2012
Slow release of organoboronic acids in cross-coupling reactions
BURKE MARTIN D14 citations91
US8318983B2Nov 27, 2012
System for controlling the reactivity of boronic acids
BURKE MARTIN D6 citations83
US9238597B2Jan 19, 2016
Apparatus and methods for the automated synthesis of small molecules
BURKE MARTIN D3 citations70
US9012658B2Apr 21, 2015
Automated synthesis of small molecules using chiral, non-racemic boronates
BURKE MARTIN D1 citations61
US8557980B2Oct 15, 2013
Methods for forming protected organoboronic acids
BURKE MARTIN D3 citations58
US9862733B2Jan 9, 2018
Apparatus and methods for the automated synthesis of small molecules
BURKE MARTIN D0 citations49
US9353131B2May 31, 2016
Methods for forming protected organoboronic acids
BURKE MARTIN D0 citations48
VIIV HEALTHCARE UK NO 5 LTD
4 patentsUS11541055B2Jan 3, 2023
Inhibitors of human immunodeficiency virus replication
VIIV HEALTHCARE UK NO 5 LTD3 citations72
US11505543B2Nov 22, 2022
4-oxo-3,4-dihydroquinazoline compounds as inhibitors of human immunodeficiency virus replication
VIIV HEALTHCARE UK NO 5 LTD3 citations72
US12129255B2Oct 29, 2024
Pyrido [2,3-d]pyrimidine derivatives as inhibitors of human immunodeficiency virus replication
VIIV HEALTHCARE UK NO 5 LTD2 citations70
US12594276B2Apr 7, 2026
Inhibitors of human immunodeficiency virus replication
VIIV HEALTHCARE UK NO 5 LTD0 citations62